Telzeal-H Tab

Tablet

Treatment of hypertension (high blood pressure), especially when single-agent therapy is not adequate; helps reduce risk of cardiovascular complications associated with uncontrolled BP.

Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking AT1 receptors, lowering blood pressure. Hydrochlorothiazide is a thiazide diuretic that increases salt and water excretion via the kidneys, reducing blood volume and BP. Together they provide additive BP lowering.

Oral tablet: take as prescribed, usually once daily at the same time each day, with or without food. Swallow whole with water. Do not stop abruptly without medical advice; monitor BP regularly.

Dizziness, headache, fatigue, increased urination, dehydration, low blood pressure, electrolyte imbalance (low potassium/low sodium), nausea

Not recommended in pregnancy (may harm fetus); use caution in breastfeeding. Risk of low BP especially with dehydration/diuretics; maintain adequate fluids. Monitor kidney function and electrolytes (potassium, sodium) periodically; caution in kidney impairment, liver disease, diabetes, gout, and history of angioedema. May increase uric acid and blood sugar. Avoid potassium supplements/salt substitutes unless advised. Photosensitivity can occur with hydrochlorothiazide.

Potassium supplements/potassium-sparing diuretics (spironolactone, amiloride) and salt substitutes, lithium, NSAIDs (ibuprofen/diclofenac) may reduce effect and worsen kidney function, other antihypertensives/alcohol (additive hypotension), ACE inhibitors/aliskiren (higher risk of kidney issues and hyperkalemia—avoid in diabetes), corticosteroids (electrolyte changes), antidiabetic medicines (may need dose adjustment)

Store below 25°C in a cool, dry place away from moisture and direct light. Keep in original blister pack and out of reach of children.

Telma-H 40 Tablet, Telsar-H 40 Tablet, Telista-H 40 Tablet, Teleact-H 40 Tablet, Micardis H 40 Tablet